Skip to main content
DNA Labs India

CEP290 Gene Bardet-Biedl Syndrome Type 14 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

CEP290 Gene Bardet-Biedl Syndrome Type 14 NGS Genetic Test

Short Name: CEP290 BBS14 NGS Test

Also known as: CEP290 gene mutation analysis, BBS14 genetic test, Bardet-Biedl Syndrome Type 14 NGS test, CEP290 gene sequencing

CEP290 Gene Bardet-Biedl Syndrome Type 14 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS), Sanger sequencing for variant confirmation on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are generally issued in 3 to 4 weeks from sample receipt. Additional time may be required for variant confirmation, segregation studies, or unresolved variant classification.. Free home collection in 300+ cities across India.

NGS Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to detect disease-causing variants in the CEP290 gene associated with Bardet-Biedl syndrome type 14. It helps confirm a clinical diagnosis, identify carriers in at-risk families, and provide information for recurrence-risk assessment and reproductive counselling.

Test Code
3772
ICD Code
Q87.89
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are generally issued in 3 to 4 weeks from sample receipt. Additional time may be required for variant confirmation, segregation studies, or unresolved variant classification.
Fasting Required
No
Method
Next-Generation Sequencing (NGS), Sanger sequencing for variant confirmation
Step 1

Sample Collection

No fasting or special preparation is required. A genetic counselling session may be scheduled before the test. Please carry available clinical records, family history documents, and a valid doctor's prescription if available.

Method: Peripheral blood venepuncture or FTA card spot

Step 2

Laboratory Analysis

A trained phlebotomist will collect 2-3 ml of blood in an EDTA tube. Alternatively, an FTA card blood spot or already extracted DNA may be submitted. The collection procedure is quick and routine.

Step 3

Report Delivery

You can resume normal activities immediately. If blood was collected, keep pressure on the site for a minute. The sample will be transported to the laboratory for processing.

Timeline: Reports are generally issued in 3 to 4 weeks from sample receipt. Additional time may be required for variant confirmation, segregation studies, or unresolved variant classification.

Patient Instructions

1
Before the Test:No special preparation is required. A pre-test genetic counselling session is recommended to review the clinical history and draw a pedigree chart of family members affected with Bardet-Biedl syndrome.
2
During the Test:The sample is collected by simple blood draw or FTA card spotting. If extracted DNA is being submitted, it is forwarded to the laboratory under controlled temperature.
3
After the Test:There are no restrictions after sample collection. You may return to routine activities. The report will be shared through the online portal, email, or WhatsApp once ready.

About This Test

Who Should Get This Test

The purpose of this test is to detect disease-causing variants in the CEP290 gene associated with Bardet-Biedl syndrome type 14. It helps confirm a clinical diagnosis, identify carriers in at-risk families, and provide information for recurrence-risk assessment and reproductive counselling.

How to Prepare

  • No fasting is required
  • Carry a valid doctor's prescription or clinical history if available
  • Inform the laboratory about any recent blood transfusion or bone marrow transplant
  • For FTA card, allow the blood spot to air-dry completely before sealing in the pouch
  • For extracted DNA, send the sample in a sterile DNase-free vial at 4°C or -20°C

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Bardet-Biedl syndrome can present with genital and renal anomalies along with visual and metabolic features. This genetic test helps confirm the underlying diagnosis and supports accurate recurrence-risk counselling and reproductive planning."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml blood; or one FTA blood spot; or 1-5 μg DNA
ContainerEDTA lavender-top tube; FTA card; sterile DNA vial
Collection MethodPeripheral blood venepuncture or FTA card spot

Sample Stability

EDTA whole blood: 72 hours at 2-8°C
FTA card: stable at room temperature for several weeks after proper drying
Extracted DNA: stable for months at -20°C
Sample Rejection Criteria:
  • Clotted or haemolysed blood sample
  • Insufficient blood volume or FTA spot
  • Sample received in an inappropriate container
  • Unlabelled or incorrectly labelled sample
  • Sample without clinical history or request form

Understanding Your Results

The genetic report is interpreted by a clinical geneticist using current ACMG/AMP classification guidelines. Results should always be reviewed in the context of the patient's clinical features, family history, and genetic counselling.
📊

Pathogenic or likely pathogenic variant(s) detected

Provides strong evidence for a genetic diagnosis of Bardet-Biedl syndrome type 14 when consistent with the clinical phenotype and autosomal recessive inheritance.

Action: Clinical genetics consultation is recommended for management, family screening, and reproductive risk counselling.

📊

Single pathogenic or likely pathogenic variant detected

In an autosomal recessive disorder, this may indicate carrier status. A diagnosis of BBS type 14 usually requires two disease-causing alleles.

Action: Further testing and segregation analysis in family members are recommended.

📊

Variant of uncertain significance (VUS) detected

The variant cannot conclusively be classified as pathogenic or benign. It does not establish or exclude the diagnosis.

Action: Additional family segregation studies or complementary genetic testing may be advised.

📊

No pathogenic variant detected

Reduces the likelihood of CEP290-related BBS type 14, but does not exclude all genetic forms of Bardet-Biedl syndrome.

Action: Consider a broader BBS multi-gene panel or whole exome sequencing if clinical suspicion remains high.

⚠️ When to Consult a Doctor:

Consult a clinical geneticist or referring physician if the test identifies a pathogenic variant, likely pathogenic variant, or inconclusive result. Medical advice should also be sought for family member screening, recurrence risk, and reproductive options.

Limitations

  • This targeted test analyses only the CEP290 gene; variants in other BBS genes will not be detected
  • NGS may not reliably detect large deletions, duplications, or structural rearrangements unless specifically requested
  • Deep intronic variants and other complex variants may not be covered by standard targeted NGS
  • Some variants may be reported as variants of uncertain significance and may require additional family studies
  • A negative result does not exclude Bardet-Biedl syndrome when clinical suspicion remains high

Risks & Considerations

  • No significant physical risks are associated with blood sample collection
  • Minor bruising, bleeding, or discomfort may occur at the venepuncture site
  • Psychological impact from learning about a genetic diagnosis or carrier status
  • Uncertainty due to variants of uncertain significance
  • Privacy and confidentiality risks despite secure handling

Interfering Factors

  • Recent allogeneic bone marrow transplant can affect blood-based DNA analysis
  • Recent major blood transfusion may influence whole blood-derived DNA results
  • Poor DNA quality or quantity can lead to incomplete sequencing
  • Sample mix-up or contamination with another individual's DNA

Compare With Similar Tests

TestCEP290 Gene Bardet-Biedl Syndrome Type 14 NGS Genetic Test
ComparisonCEP290 Gene Bardet-Biedl Syndrome Type 14 NGS Genetic Test

Frequently Asked Questions

What is the price of the CEP290 gene Bardet-Biedl syndrome type 14 NGS genetic test?
The test costs Rs 20000 at DNA Labs India. Free home sample collection is available for online bookings.
What sample type is needed for this test?
The test can be performed on blood, extracted DNA, or one drop of blood on an FTA card.
Is fasting required before giving the sample?
No, fasting is not required for this genetic test.
How long will the report take?
Reports are usually available in 3 to 4 weeks after the sample is received by the laboratory.
What is Bardet-Biedl syndrome?
Bardet-Biedl syndrome is a rare autosomal recessive disorder affecting multiple organ systems. It often causes retinal dystrophy, obesity, polydactyly, kidney abnormalities, and learning difficulties.
Why is the CEP290 gene tested?
Mutations in the CEP290 gene are a common cause of Bardet-Biedl syndrome type 14. The gene is involved in ciliary function, which is important for many organs and tissues.
What is next-generation sequencing?
Next-generation sequencing, or NGS, is a high-throughput method that can sequence multiple genes or gene regions at once. It allows rapid and accurate analysis of the CEP290 gene.
Can this test be used for carrier testing?
Yes, carrier testing can be offered to at-risk adult relatives when a CEP290 pathogenic variant has already been identified in the family. Genetic counselling is recommended.
Does a negative result completely rule out Bardet-Biedl syndrome?
No. A negative result reduces the likelihood of CEP290-related BBS type 14, but BBS can also be caused by variants in other genes. A broader BBS panel may be needed if clinical suspicion remains high.
Will this test detect mutations in other BBS genes?
No, this is a targeted CEP290 gene test. Other BBS genes are not analysed as part of this specific test.
Do I need genetic counselling before the test?
Genetic counselling is strongly recommended before and after testing. It helps in understanding the inheritance pattern, limitations of the test, and implications for family members.
How do I book this test with DNA Labs India?
You can book online through the DNA Labs India website. Home sample collection is available free of cost across many cities in India.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.